Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration ... more options and greater ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19 ... which could lead to treatments for the cognitive symptoms of Parkinson's ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

Just 2.1 per cent of people with dementia undergo specialist investigations – such as having MRI or PET scans, which would be required for treatment with the breakthrough drugs lecanemab and ...